17.05.10
Nycomed and Forest Laboratories receive complete FDA response letter for Roflumilast – no additional patient trials were requested
11.05.10
Nycomed’s first quarter 2010 results confirm the direction
27.04.10
GE Healthcare and Nycomed to form joint venture to sell, market and distribute medical diagnostic contrast agents in Russia and CIS